Literature DB >> 21528090

Markers of bile duct tumors.

Giulia Malaguarnera1, Maria Giordano, Isabella Paladina, Alessandra Rando, Mario Uccello, Francesco Basile, Antonio Biondi, Santo Carnazzo, Innocenza Alessandria, Clorinda Mazzarino.   

Abstract

Biliary tract carcinomas are relatively rare, representing less than 1% of cancers. However, their incidence has increased in Japan and in industrialized countries like the USA. Biliary tract tumors have a poor prognosis and a high mortality rate because they are usually detected late in the course of the disease; therapeutic treatment options are often limited and of minimal utility. Recent studies have shown the importance of serum and molecular markers in the diagnosis and follow up of biliary tract tumors. This review aims to introduce the main features of the most important serum and molecular markers of biliary tree tumors. Some considerable tumor markers are cancer antigen 125, carbohydrate antigen 19-9, carcinoembryonic antigen, chromogranin A, mucin 1, mucin 5, alpha-fetoprotein, claudins and cytokeratins.

Entities:  

Keywords:  Bile duct tumors; Carbohydrate antigen 19-9; Cholangiocarcinoma; Chromogranin A; Tumor markers

Year:  2011        PMID: 21528090      PMCID: PMC3083496          DOI: 10.4251/wjgo.v3.i4.49

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  165 in total

Review 1.  Ki-67 staining as a means to simplify analysis of tumor cell proliferation.

Authors:  C L Hitchcock
Journal:  Am J Clin Pathol       Date:  1991-10       Impact factor: 2.493

2.  Immunohistochemical demonstration of human carbonic anhydrase isoenzyme II in brain tumours.

Authors:  A K Parkkila; R Herva; S Parkkila; H Rajaniemi
Journal:  Histochem J       Date:  1995-12

Review 3.  Tight junctions.

Authors:  M S Balda; K Matter
Journal:  J Cell Sci       Date:  1998-03       Impact factor: 5.285

4.  Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma.

Authors:  S Nakamura; S Suzuki; T Sakaguchi; A Serizawa; H Konno; S Baba; S Baba; H Muro
Journal:  Cancer       Date:  1996-10-15       Impact factor: 6.860

Review 5.  The role of immunity in elderly cancer.

Authors:  Lucia Malaguarnera; Erika Cristaldi; Mariano Malaguarnera
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-04       Impact factor: 6.312

Review 6.  Human carbonic anhydrases and carbonic anhydrase deficiencies.

Authors:  W S Sly; P Y Hu
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

7.  Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.

Authors:  Jun Zheng; Yao-Ming Zhu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-08

8.  Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components.

Authors:  J Wesseling; S W van der Valk; H L Vos; A Sonnenberg; J Hilkens
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

9.  CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.

Authors:  J-L Pujol; O Molinier; W Ebert; J-P Daurès; F Barlesi; G Buccheri; M Paesmans; E Quoix; D Moro-Sibilot; M Szturmowicz; J-M Bréchot; T Muley; J Grenier
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  Elevation of serum alpha-fetoprotein and proliferation of oval cells in the livers of LEC rats.

Authors:  H Takahashi; M Oyamada; Y Fujimoto; M I Satoh; A Hattori; K Dempo; M Mori; T Tanaka; H Watabe; R Masuda
Journal:  Jpn J Cancer Res       Date:  1988-07
View more
  13 in total

1.  Correlation of CEA but not CA 19-9 as serum biomarkers of disease activity in a case of metastatic rectal adenocarcinoma.

Authors:  Eric I Marks; Matthew Brennan; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Extrahepatic biliary cancer: New staging classification.

Authors:  Dhakshinamoorthy Ganeshan; Fanny E Moron; Janio Szklaruk
Journal:  World J Radiol       Date:  2012-08-28

3.  Elevated serum levels of Chromogranin A in hepatocellular carcinoma.

Authors:  Antonio Biondi; Giulia Malaguarnera; Marco Vacante; Massimiliano Berretta; Velia D'Agata; Michele Malaguarnera; Francesco Basile; Filippo Drago; Gaetano Bertino
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

4.  Efficacy and Safety of Apatinib Treatment for Advanced Cholangiocarcinoma After Failed Gemcitabine-Based Chemotherapy: An Open-Label Phase II Prospective Study.

Authors:  Ge Zhang; Shuai Gong; Lina Pang; Lixia Hou; Wei He
Journal:  Front Oncol       Date:  2021-05-03       Impact factor: 6.244

5.  Risk of hepatocellular carcinoma in workers exposed to chemicals.

Authors:  Mario Uccello; Giulia Malaguarnera; Thea Corriere; Antonio Biondi; Francesco Basile; Mariano Malaguarnera
Journal:  Hepat Mon       Date:  2012-10-11       Impact factor: 0.660

6.  Common bile duct adenocarcinoma in a patient with situs inversus totalis: report of a rare case.

Authors:  Hafida Benhammane; Saoussane Kharmoum; Sylvain Terraz; Thierry Berney; Thai Nguyen-Tang; Muriel Genevay; Omar El Mesbahi; Arnaud Roth
Journal:  BMC Res Notes       Date:  2012-12-12

7.  Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.

Authors:  Giuliana Cavalloni; Caterina Peraldo-Neia; Chiara Varamo; Laura Casorzo; Carmine Dell'Aglio; Paola Bernabei; Giovanna Chiorino; Massimo Aglietta; Francesco Leone
Journal:  Tumour Biol       Date:  2015-10-20

8.  Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma.

Authors:  Michelle X Yang; Ryan F Coates; Abiy Ambaye; Juli-Anne Gardner; Richard Zubarick; Yuan Gao; Joan Skelly; James G Liu; Mari Mino-Kenudson
Journal:  Biomark Res       Date:  2018-07-27

9.  Carbohydrate 19.9 antigen serum levels in liver disease.

Authors:  Gaetano Bertino; Annalisa Maria Ardiri; Giuseppe Stefano Calvagno; Giulia Malaguarnera; Donatella Interlandi; Marco Vacante; Nicoletta Bertino; Francesco Lucca; Roberto Madeddu; Massimo Motta
Journal:  Biomed Res Int       Date:  2013-10-27       Impact factor: 3.411

10.  Dynamics of liver enzymes in rabbits experimentally infected with Fasciola sp. (Intermediate form from Japan).

Authors:  Wipaporn Jarujareet; Kensuke Taira; Hong Kean Ooi
Journal:  J Vet Med Sci       Date:  2017-11-09       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.